A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma (AGuo)

Share this content:
A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma (AGuo)

Sponsor and Collaborators
Chinese Academy of Medical Sciences
Beijing University of Chinese Medicine
China Medical University, China
Peking Union Medical College Hospital
Tianjin Medical University
Shanghai Jiao Tong University School of Medicine
Changhai Hospital
Zhejiang University
Fudan University
Jiangsu Province Centers for Disease Control and Prevention
Central South University
Sichuan University
Huazhong University of Science and Technology

Contact
China Academy of Medical Sciences Jianhui Ma China Academy of Medical Sciences
01086108778

ClinicalTrials.gov Identifier
NCT01041482
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters